Effect of the Proprotein Convertase Subtilisin/Kexin 9 Monoclonal Antibody, AMG 145, in Homozygous Familial Hypercholesterolemia von Stein, Evan A, Honarpour, Narimon, Wasserman, Scott M, Xu, Feng, Scott, Rob, Raal, Frederick J

Volltext

Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events von Sabatine, Marc S, Giugliano, Robert P, Wiviott, Stephen D, Raal, Frederick J, Blom, Dirk J, Robinson, Jennifer, Ballantyne, Christie M, Somaratne, Ransi, Legg, Jason, Wasserman, Scott M, Scott, Robert, Koren, Michael J, Stein, Evan A

Volltext

Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial von Raal, Frederick J, Prof, Honarpour, Narimon, MD, Blom, Dirk J, MD, Hovingh, G Kees, MD, Xu, Feng, MS, Scott, Rob, MD, Wasserman, Scott M, MD, Stein, Evan A, Prof

Volltext

Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable st... von Stein, Evan A, Prof, Dr, Gipe, Dan, MD, Bergeron, Jean, MD, Gaudet, Daniel, Prof, Weiss, Robert, MD, Dufour, Robert, MD, Wu, Richard, PhD, Pordy, Robert, MD

Volltext

Reduction of Low-Density Lipoprotein Cholesterol by Monoclonal Antibody Inhibition of PCSK9 von Stein, Evan A, Raal, Frederick

Volltext

Safety and Efficacy of a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease, SAR236553/REGN727, in Patients With Primary Hypercholesterolemia Rece... von McKenney, James M., PharmD, Koren, Michael J., MD, CPI, Kereiakes, Dean J., MD, Hanotin, Corinne, MD, Ferrand, Anne-Catherine, MSc, Stein, Evan A., MD, PhD

Volltext

A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia von Blom, Dirk J, Hala, Tomas, Bolognese, Michael, Lillestol, Michael J, Toth, Phillip D, Burgess, Lesley, Ceska, Richard, Roth, Eli, Koren, Michael J, Ballantyne, Christie M, Monsalvo, Maria Laura, Tsirtsonis, Kate, Kim, Jae B, Scott, Rob, Wasserman, Scott M, Stein, Evan A

Volltext

PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial von Raal, Frederick J, Prof, Stein, Evan A, Prof, Dufour, Robert, MD, Turner, Traci, MD, Civeira, Fernando, MD, Burgess, Lesley, Prof, Langslet, Gisle, MD, Scott, Russell, Prof, Olsson, Anders G, Prof, Sullivan, David, MD, Hovingh, G Kees, MD, Cariou, Bertrand, MD, Gouni-Berthold, Ioanna, MD, Somaratne, Ransi, MD, Bridges, Ian, MSc, Scott, Rob, MD, Wasserman, Scott M, MD, Gaudet, Daniel, Prof

Volltext

Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol von Stein, Evan A, Mellis, Scott, Yancopoulos, George D, Stahl, Neil, Logan, Douglas, Smith, William B, Lisbon, Eleanor, Gutierrez, Maria, Webb, Cheryle, Wu, Richard, Du, Yunling, Kranz, Therese, Gasparino, Evelyn, Swergold, Gary D

Volltext

Effect of Alirocumab, a Monoclonal Proprotein Convertase Subtilisin/Kexin 9 Antibody, on Lipoprotein(a) Concentrations (a Pooled Analysis of 150 mg Every Two Weeks Dosing from Phas... von Gaudet, Daniel, MD, PhD, Kereiakes, Dean J., MD, McKenney, James M., PharmD, Roth, Eli M., MD, Hanotin, Corinne, MD, Gipe, Daniel, MD, Du, Yunling, PhD, Ferrand, Anne-Catherine, MSc, Ginsberg, Henry N., MD, Stein, Evan A., MD, PhD

Volltext

PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role[S] von Raal, Frederick J., Giugliano, Robert P., Sabatine, Marc S., Koren, Michael J., Blom, Dirk, Seidah, Nabil G., Honarpour, Narimon, Lira, Armando, Xue, Allen, Chiruvolu, Padmaja, Jackson, Simon, Di, Mei, Peach, Matthew, Somaratne, Ransi, Wasserman, Scott M., Scott, Rob, Stein, Evan A.

Volltext

Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial von Fayad, Zahi A, Prof, Mani, Venkatesh, PhD, Woodward, Mark, Prof, Kallend, David, MB BS, Abt, Markus, PhD, Burgess, Tracy, MSc, Fuster, Valentin, Prof, Ballantyne, Christie M, Prof, Stein, Evan A, Prof, Tardif, Jean-Claude, Prof, Rudd, James H F, MD, Farkouh, Michael E, MD, Tawakol, Ahmed, MD

Volltext

Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset ana... von Raal, Frederick J, Prof, Hovingh, G Kees, PhD, Blom, Dirk, MD, Santos, Raul D, Prof, Harada-Shiba, Mariko, Prof, Bruckert, Eric, Prof, Couture, Patrick, MD, Soran, Handrean, Prof, Watts, Gerald F, Prof, Kurtz, Christopher, MD, Honarpour, Narimon, MD, Tang, Lihua, PhD, Kasichayanula, Sree, PhD, Wasserman, Scott M, MD, Stein, Evan A, Prof

Volltext

Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145) von Raal, Frederick J., MB BCh, MMed, PhD, Giugliano, Robert P., MD, SM, Sabatine, Marc S., MD, MPH, Koren, Michael J., MD, Langslet, Gisle, MD, Bays, Harold, MD, Blom, Dirk, PhD, MD, Eriksson, Mats, MD, Dent, Ricardo, MD, Wasserman, Scott M., MD, Huang, Fannie, MS, Xue, Allen, PhD, Albizem, Moetaz, MD, Scott, Rob, MD, Stein, Evan A., MD, PhD

Volltext

Efficacy and tolerability of adding prescription Omega-3 fatty acids 4 g/d to Simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-con... von Davidson, Michael H., MD, Stein, Evan A., MD, PhD, Bays, Harold E., MD, Maki, Kevin C., PhD, Doyle, Ralph T, Shalwitz, Robert A., MD, Ballantyne, Christie M., MD, Ginsberg, Henry N., MD

Volltext

MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia? von Momtazi, Amir Abbas, Banach, Maciej, Pirro, Matteo, Stein, Evan A., Sahebkar, Amirhossein

Volltext

Potential of Proprotein Convertase Subtilisin/Kexin Type 9 Based Therapeutics von Stein, Evan A., Swergold, Gary D.

Volltext

Effect of Lipid-Lowering Treatment on Natural History of Heterozygous Familial Hypercholesterolemia in Past Three Decades von Elis, Avishay, MD, Zhou, Rong, PhD, Stein, Evan A., MD

Volltext

Non-statin Treatments for Managing LDL Cholesterol and Their Outcomes von Turner, Traci, MD, Stein, Evan A., MD, PhD

Volltext

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial) von Jones, Peter H, Davidson, Michael H, Stein, Evan A, Bays, Harold E, McKenney, James M, Miller, Elinor, Cain, Valerie A, Blasetto, James W

Volltext